ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 717838 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 717838; 2) Community: the network communities that were significantly associated with the response to NSC 717838; 3) Molecule: the relationships between components within communities and NSC 717838; 4) MDR: the compounds that were significantly associated with the NSC 717838.

NSC Compound Enrichment Correlation
NSC 622075 Null 0.00423163567577548 -0.28906121
NSC 641319 5,12-Naphthacenedione, 10-[[3-[[5,5-di(acetyloxy)pentyl]amino]- 2,3,6-trideoxy-.alpha.-L-lyxohexopyranosyl]oxy]- 7,8,9,10-tetrahydro-6,8,11-trihydroxy- 8-(hydroxyacetyl)-1-methoxy-, hydrochloride 0.00423163567577548 -0.27979875
NSC 650594 Null 0.00423163567577548 -0.19141227
NSC 661941 2-(3-chloropropyloxy)naphthazarin 0.00423163567577548 -0.33738602
NSC 740 Methotrexate 0.00423163567577551 -0.20645612
NSC 753769 Null 0.00423163567577551 0.3085883
NSC 624205 Null 0.00550789647802199 -0.27802407
NSC 643735 5H-Benzo[a]phenoxazine,10-(D,L-alanyl)-5-oxo-, mononitrate salt 0.00550789647802199 -0.27598769
NSC 650772 4-Methylthio-N-(3,4,5-trimethoxybenzyl)aniline Hydrochloride 0.00550789647802199 -0.10172553
NSC 682429 2-(1-Propynyl)-3,17.beta.-estradiol 0.00550789647802199 -0.15250485
Total:55  Current:7    [First] [Prev] [Next] [Last]